Anyone who has tried to classify cancer types from real-world datasets knows the feeling: labels bleed into each other, subtypes behave like different species within the same class, and the rare classes you care about most are the ones your model overlooks. At AI Tech Inspire, we spotted a researcher navigating exactly this terrain and distilled the practical moves teams can use when class overlap, heterogeneity, and imbalance collide.

Quick facts from the problem setup

  • Data spans multiple cancer types (multi-class) with heavy class overlap and within-class heterogeneity.
  • Significant class imbalance is present; SMOTE oversampling produced noisy samples due to overlap.
  • Class weights outperformed naive resampling.
  • Batch effects and technical artifacts were addressed, yet class-specific signals remain faint.
  • Splitting into binary tasks (e.g., one-vs-rest) didn’t fully resolve imbalance issues.
  • The overlap and heterogeneity are biologically expected, meaning data difficulty is intrinsic.

Why cancer data feels adversarial (even when it isn’t)

Unlike clean benchmarks, cancer datasets often reflect messy biology: intratumoral heterogeneity, evolving clonal populations, and measurement noise from different platforms and labs. When classes truly overlap, a model isn’t just “failing” — it’s being asked to draw hard boundaries where nature left gradients.

Key takeaway: Before forcing separation with brute-force sampling, assume overlap is real and plan for uncertainty, cost-sensitivity, and decision support rather than a single hard label.

Resampling: not just SMOTE — when and how to use it

When overlap is high, plain SMOTE can interpolate across class boundaries and make the minority class look like noise. If you must oversample, consider variants that respect local structure:

  • Borderline-SMOTE: focuses on ambiguous regions near class boundaries to synthesize more informative minority samples.
  • SMOTE-ENN or SMOTE-Tomek: combine oversampling with cleaning (Edited Nearest Neighbors or Tomek links) to remove borderline and mislabeled points.
  • Cluster-aware oversampling: apply k-means (or similar) within the minority class to oversample underrepresented subclusters, preserving heterogeneity.

That said, when overlap is genuine, cost-sensitive learning often beats any sampling trick. Use resampling sparingly and validate with leakage-proof cross-validation.

Cost-sensitive learning and better losses

Class weights are a strong start. They tell the model that false negatives in rare classes are more costly. Build on this:

  • Per-sample weights: In frameworks like XGBoost and scikit-learn, you can pass instance-level weights. This generalizes beyond binary-only options.
  • Focal loss for neural models: down-weights easy examples, emphasizing ambiguous or minority instances. It’s straightforward to implement in PyTorch or TensorFlow.
  • Label smoothing: reduces overconfidence in overlapped regions, often improving calibration.

If deploying in clinical decision support, calibrated probabilities matter more than raw logits. Pair your model with Platt scaling or isotonic regression, and track Brier score and ECE alongside accuracy.

Structure the problem to match the biology

Flat multi-class labels can hide useful structure:

  • Hierarchical classification: Model taxonomy (e.g., primary site → subtype). Errors become “closer” to truth and can be more clinically tolerable.
  • One-vs-rest with thresholds
  • Use class-specific thresholds tuned via PR-AUC or F1 on each OVR head. Consider top-k predictions and tie-breaking by calibrated probability.
  • Multi-task learning: Predict related labels (e.g., histology, molecular signatures) jointly to share signal across tasks.
  • Representation learning: Contrastive or metric learning (triplet loss) separates clusters in embedding space before classification.

When heterogeneity is severe, start by discovering the heterogeneity. Cluster within each class to reveal subtypes, then train a classifier to distinguish discovered subclusters. This mixture-of-experts approach often stabilizes decision boundaries.

Model choices that tolerate overlap and noise

  • Tree ensembles: Gradient boosting (e.g., XGBoost, LightGBM, CatBoost) with weighted loss and careful regularization handle nonlinearity and mixed feature types well. Calibrate after training.
  • Random Forest: Strong baselines, especially with class weights and balanced subsampling.
  • SVM with class weights: Soft-margin SVMs can maximize margins in overlapped regions; useful as part of an ensemble.
  • Neural models: If you’ve got scale, representation learning in PyTorch or TensorFlow plus focal loss and heavy regularization can help, but tabular omics often favor trees unless you engineer embeddings.

Stacking diverse learners and averaging calibrated probabilities frequently beats any single model on these datasets.

Data polishing that moves the needle

  • Leakage-proof validation: Use group-aware folds (patient/hospital) and nested CV. Repeat stratification by class to stabilize minority metrics.
  • Label auditing: Tools like cleanlab can surface likely label errors; in overlapped data, even a small fraction of fixes helps.
  • Confound checks: Verify predictions aren’t driven by center, batch, or device. You mentioned removing batch effects; still confirm via adversarial tests (predicting batch from features should be near chance).
  • Feature aggregation: Pathway-level scores, gene set enrichment, or curated signatures reduce noise and improve interpretability. SHAP on pathway features is cleaner than on raw thousands of genes.
  • Calibration and thresholds: Separate fitting of thresholds per class using validation PR curves often yields larger gains than tinkering with model depth.

Evaluation: optimize what matters

With imbalance and overlap, accuracy can lie. Prefer:

  • Macro F1, macro PR-AUC, and per-class recall/precision.
  • Top-k accuracy for triage use-cases where a shortlist is acceptable.
  • Decision curve analysis or cost curves when false negatives vs. false positives have asymmetric cost.
  • Calibration metrics (Brier, ECE) to ensure probabilities support downstream decisions.

Also consider selective prediction: abstain when unsure. Conformal prediction or entropy-based rejection lets the system hit Esc on edge cases, routing them to expert review.

A practical recipe you can run this week

  • Start with a strong baseline: weighted XGBoost or CatBoost, repeated stratified nested CV, macro PR-AUC as the target metric.
  • Audit labels and confounders; remove or down-weight suspected noisy points (cleanlab or nearest-neighbor consensus).
  • Engineer pathway- or panel-level features; reduce dimensionality with supervised or contrastive embeddings.
  • Try hierarchical or OVR decomposition; set per-class thresholds using validation PR curves.
  • If oversampling is needed, test Borderline-SMOTE or SMOTE-ENN only within training folds.
  • Calibrate with isotonic regression; report both calibrated PR-AUC and Brier score.
  • Add a selective prediction layer (conformal) to abstain on low-confidence predictions.
  • Inspect SHAP at the pathway level to confirm signals align with domain knowledge.

Tooling tips

  • Classic pipelines: scikit-learn + imbalanced-learn for resampling + calibration + OVR/OVO wrappers.
  • Boosting: XGBoost with instance weights; tune depth, min child weight, and gamma to reduce overfitting in overlapped regions.
  • Deep learning: implement focal loss and contrastive pretraining in PyTorch or TensorFlow; leverage mixed precision with CUDA when applicable.
  • Model hub and metrics: keep experiment tracking tidy; resources on Hugging Face are useful even for tabular workflows (datasets, evaluation recipes).

Why this matters for engineers

In domains like oncology, the hard part isn’t model choice — it’s engineering a pipeline that respects biological ambiguity, quantifies uncertainty, and optimizes the right trade-offs. Treat the problem less like a leaderboard chase and more like building a safe, calibrated assistant. If your system can say “top-2 candidates with confidence, otherwise defer,” it becomes useful in ways a brittle hard-label classifier never will.

For teams wrestling with overlapping, imbalanced classes, the combination of cost-sensitive learning, hierarchy or OVR decomposition, calibrated probabilities, and selective prediction is a high-yield path. It won’t make the biology simpler, but it will make your model’s behavior more trustworthy — and that’s where real-world impact starts.

Recommended Resources

As an Amazon Associate, I earn from qualifying purchases.